Sand Clinic is the Stockholm proactive-care clinic backed by Spotify founders Daniel Ek and Martin Lorentzon. The public promise is deep diagnostics plus a care team that turns data into a protocol; the missing public variable is price.
This profile synthesizes the clinic’s published information, reputable coverage and first-hand accounts. We have not audited the clinic on your behalf, and we say so.
“Interesting because it is Nordic, physician-led and backed by serious founders. Still a qualify page, not a buy page, until pricing, test list and follow-up scope are public enough to compare.”
Sand Clinic’s site describes a proactive-care model focused on early signals, measurable risk factors, deep diagnostics and a care team spanning medicine, nutrition, sleep and mental health.
Sifted and other industry coverage reported that Daniel Ek and Martin Lorentzon backed the clinic, with early membership expectations between €1,000 and €10,000 per month. The official site currently does not publish a clear price table.
Most longevity-clinic pages are US or luxury-retreat coded. Sand is interesting because it sits in the Nordic healthcare context and appears to sell longitudinal care, not only a scan.
If the care team is real and the protocol is specific, that can be more valuable than another broad panel. If pricing remains opaque, buyers should slow down.
Ask for the current membership price, exact annual test list, imaging scope, visit cadence, who reviews abnormal results, whether specialists are included, and how your data exports to an outside physician.
Also ask whether the program is a membership, a single baseline, or both. The spend logic changes completely depending on the answer.
Wait if you need a transparent one-time price before booking. Neko is clearer for a single baseline; Human Longevity and HOOKE are clearer for high-ticket packages.
Consider Sand only if the private quote makes the follow-up relationship explicit enough to justify the commitment.
A care-team model can be more useful than another standalone scan when it turns risk markers into specific decisions. But public buyers cannot evaluate that from brand backing alone.
Until price, test scope and ownership of abnormal findings are clear, Sand belongs in the qualify lane. The right buyer asks for the operating model in writing before comparing it with Neko, HOOKE or a conventional executive physical.
Sand Clinic does not publish a clear price table on its official site. Early coverage expected memberships between €1,000 and €10,000 per month, so buyers should confirm current pricing directly.
No. Neko is a transparent one-visit scan model. Sand appears to be a proactive-care membership with diagnostics and an ongoing care team.
Only after receiving the current price, test list, visit cadence and follow-up pathway in writing. The concept is interesting; the public pricing is not yet transparent enough for a clean Agewell buy verdict.
The main risk is not the concept; it is opacity. Without a public price table and exact test list, a buyer cannot compare Sand cleanly against Neko, HOOKE or Human Longevity.
By David Persson · Updated 2026-06-12 · Pricing changes – confirm with the clinic · Corrections: hi@agewell.guide
The Agewell Briefing
One letter a week – what to buy, what to question, what to skip. No sponsors inside the letter, ever.
One email a week. Unsubscribe with one click.